Article Details
Retrieved on: 2025-10-02 22:48:22
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... biopharma industry and positioning Halozyme for continued long-term revenue growth through Elektrofi's licensing, royalty revenue business model.”.
Article found on: www.pharmaceutical-technology.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here